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KEY POINTS
 Telemedicine encompasses the use of information and communication technology (telephone,
video, Internet, satellite, cloud) to deliver health care at a distance.
 Diagnostic telemedicine applications include telemonitored polysomnography, long-term poly-
graphic monitoring, and remote continuous positive airway pressure (CPAP) titration.
 Telemedicine allows clinicians to remotely monitor CPAP adherence and compliance and fine-tune
CPAP settings.
 Patient counseling, as well as therapy reinforcement by combining and integrating psychoeduca-
tional interventions and telemonitoring, is feasible.
 Barriers like patient’s and physician’s cooperation, privacy concerns, financial barriers, technolog-
ical barriers, and quality concerns have to be overcome.INTRODUCTION
The popularity of technology is increasing in nearly
every field, and sleep medicine is no exception.
Telemedicine as a means of remote patient-
physician interaction is growing and virtual consul-
tations with sleep specialists are feasible.1 The
potential benefits of telemedicine include
improved access to health care, reduced waiting
time for appointments, and increased adherence
to chronic illness treatment plans.2 Because
many sleep disorders, particularly sleep apnea,
are chronic conditions, and require a continuous
treatment and monitoring of therapy success,
telematic communications and new information
technologies could be useful to establish diag-
nostic and therapeutic strategies. It is important
to install cost-efficient technologies for an initial
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and compliance, providing the possibility for pa-
tients to avoid traveling.3 A substantial proportion
of patients are willing to consider telemedicine as
an option for their care. In such settings, in case
of insufficient adherence or compliance, device
dysfunction, or subjective problems, alerts can
be generated and sent to the health professional,
who can react rapidly and focus on the patient’s
needs.
In this article, telemedicine solutions in sleep
disordered breathing are reviewed, with emphasis
on adherence and compliance monitoring:
 Diagnostic telemedicine applications: telemo-
nitored polysomnography, long-term poly-
graphic monitoring.
 Remote continuous positive airway pressure
(CPAP) titration.leep Disorders Centre, Antwerp University Hospital,
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Verbraecken446 Monitoring of CPAP adherence and
compliance:
 Standard care
 Remote monitoring and fine-tuning therapy
 Patient counseling and therapy reinforcement
by combining and integrating the most prom-
ising elements of both psychoeducational
interventions and technological innovations.
 Barriers in the implementation of telemedicine
are also highlighted.DIAGNOSTIC TELEMEDICINE APPLICATIONS
Telemonitored Polysomnography
Telemonitored polysomnography (PSG) is
designed to overcome the disadvantages of
home recordings and could provide an organiza-
tional solution to the overloading of specialized
sleep centers. Dedicated technicians regularly
verify, at a distance, the quality of the PSG record-
ings by means of periodic access to the PSG
monitoring device. From a telemonitoring control
panel, they are able to insert comments in the
recording; adjust transducer gain; and, in the event
of an artifact or an undesirable accident, inform the
patient by telephone.4 However, evidence on the
efficacy of telemonitored PSG is weak. Gagna-
doux and colleagues5 reported that PSG per-
formed in a local hospital and telemonitored by a
sleep laboratory was clearly superior to unat-
tended home PSG. Kristo and colleagues6 pro-
posed a telemedicine protocol for the online
transfer of PSG data from a remote site to a
centralized sleep laboratory, which provided a
cost-saving approach for the diagnosis of obstruc-
tive sleep apnea (OSA). Their system was based
on the transmission of data using an Internet file
transfer protocol (FTP), which is the conventional
system for file transfer. Kayyali and colleagues7
presented a new compact telemetry-based sleep
monitor, consisting of a 14-channel wearable wire-
less monitor and a cell phone–based gateway to
transfer data, including video, in real time from
the patient’s home to a remote sleep center. The
monitor can easily be worn and transported, and
it offers reliable recordings. The receiver is a sepa-
rate unit connected with the back of the display.
Internal Bluetooth receivers, usually included in
laptops, can also be used instead of a dedicated
external Bluetooth receiver. A major problem
encountered with home sleep studies is the poten-
tial loss of data in about 4.7% to 20% of the cases,
which results in lower than expected cost
savings.8 Using Sleepbox technology (Medatec,
Brussels, Belgium), a wireless system able to
communicate with the polysomnograph and with
Internet through a WiFi/3G interface, andcommunicating via Skype, the investigators were
able to deliver recordings with excellent quality in
90% of the cases.9 This finding suggests an inter-
esting way to decrease the failure rate of home
sleep studies, although it is still problematic, and
some technical aspects need to be improved.
Pelletier-Fleury and colleagues10 comparatively
evaluated the cost and effectiveness of PSG tele-
monitoring and PSG by conventional unsuper-
vised home monitoring, and showed that remote
telemonitoring made the procedure clearly supe-
rior from a technical point of view and was
preferred by the patients. The cost of PSG telemo-
nitoring was US$244, whereas the cost of PSG
with conventional unsupervised home monitoring
was US$153. The health care infrastructure sav-
ings have to be taken into account as well. For
example, by adding up the working days that the
patients did not lose and the round-trip travel
costs they avoided, it can be estimated that the
real cost would be similar or lower than that of con-
ventional PSG.3 Masa and colleagues11 compared
the costs made between device transportation
and telematic transmission of data, with compara-
ble results. Having devices moved by a transporta-
tion company or sent telematically as raw data
proved cost-effective and equally beneficial. This
finding opens the possibility of application among
patients who live a long way from the hospital or
those with limited mobility. Fields and colleagues12
showed the feasibility of a comprehensive,
telemedicine-based OSA evaluation and manage-
ment pathway compared with a more traditional,
in-person care model. They combined video
consultation for intake with home sleep testing us-
ing a type 3 portable monitor with remote down-
load, and automatic CPAP (autoCPAP) titration
with wireless modem technology. Patient satisfac-
tion, CPAP adherence and compliance, and
improvement in quality of life were similar in both
groups.Long-Term Polygraphic Monitoring
In clinical practice, the use of PSG is a standard
procedure to assess sleep disordered breathing.
However, PSG is not suitable for chronic moni-
toring in the home environment. New telemedicine
applications have become available using a home
appliance as a precautionary measure for moni-
toring snoring and OSA. Seo and colleagues13
developed a nonintrusive health-monitoring
home system to monitor patients’ electrocardio-
gram (ECG) results, weight, motor activity, and
snoring. Choi and colleagues14 proposed a ubiqui-
tous health-monitoring system in a bedroom,
which monitors the ECG, body movements, and
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colleagues15 evaluated the feasibility of night-
time pulse-oximetry telemedicine to screen pa-
tients at risk for OSA. They concluded that the
technique seemed to be suitable and cost-
effective, with high sensitivity and specificity.
This approach can be applied in a telemedicine
referral network for early diagnosis of OSA, and
the reading could be transmitted to the relevant
sleep laboratory, examined, and the results
returned to the referring physician.16
THERAPEUTIC TELEMEDICINE APPLICATIONS
Remote Continuous Positive Airway Pressure
Titration
An exploratory study was set up to perform real-
time titration of domiciliary CPAP.17 The novelty
of this approach is that a telemetry unit is con-
nected to a commercially available CPAP device
to allow a low-cost, 2-way communication channel
in real time between the sleep laboratory techni-
cian and the CPAP device in the patient’s home.
The approach requires no special telemedicine
approach, nor does it require the patient’s active
cooperation or any kind of communication infra-
structure (computer or the Internet) in the patient’s
home.
Monitoring of Continuous Positive Airway
Pressure Compliance and Adherence
Continuous positive airway pressure adherence
and compliance
BecauseCPAP is a self-administered treatment, its
efficacy is critically dependent on the patient’s will-
ingness to use the device and apply the nasalmask
during sleep, regardless of how well a CPAP ma-
chine corrects apnea. In this context, the term
adherence is used to describe continued use of
the machine (ie, uptake), whereas compliance
expresses the use of CPAP for a certain amount
of time.18 However, these terms are often inade-
quately used and interchangeable. A user is
defined as a patient who uses the device for greater
than 4 hours per night. Commonly used definitions
of adequate compliance are usage of greater than
4 hours per night for 70% of days or greater than
4 hours per night for more than 5 d/wk.19,20
Different studies have shown that the rates of
CPAP use are between 30% and 60%. Note that
patients who become nonadherent in the first
days of CPAP treatment generally remain nonad-
herent.21 Without optimal CPAP use, patients fail
to achieve the full cardiovascular and symptomatic
benefits of therapy.
Hence, compliance for CPAP should be
regarded as the main determinant for success.18Self-reports are an inaccurate tool to determine
compliance with CPAP therapy for OSA. Trying
to estimate daily use time by simply questioning
how many hours a night the patient uses the
device generally results in a considerable misesti-
mation of mean treatment time per night, because
the patient is likely to provide the number of hours
of CPAP use solely for the nights it was worn.
Including the question about the number of nights
on CPAP per week makes self-reports of CPAP
use more accurate. This discrepancy may be
attributed to not using the machine when traveling,
during episodes of upper airway infection, or dur-
ing self-prescribed treatment vacations from time
to time. Another explanation is that many patients
do not reestablish CPAP after the first awakening
in the morning. Altogether, a more objective
approach is mandatory. At present, CPAP usage
is assessed by using time meters or more sophis-
ticated devices that measure both run time and
pressure delivery. It is increasingly accepted in
sleep medicine that good compliance consists of
4 hours or more of CPAP per night and 70% of
the nights, and that this is needed to achieve
optimal symptom control.22,23 The literature shows
that between 29% and 83% of patients do not
meet the criteria for good compliance because of
removing CPAP early in the night and/or discontin-
uing use. Patients’ perceptions of CPAP within the
first weeks of using the machine affect the long-
term results of CPAP adherence and compli-
ance.24 Objective compliance can be obtained
from the average number of hours of running of
the machine per 24 hours, calculated from the
built-in time counter of the device, but, preferably,
effective compliance is assessed based on the
time spent at the prescribed effective pressure
per night, using a pressure monitor coupled with
a microprocessor.25 Microprocessors use an algo-
rithm for the detection of mask-on pressure. The
variable component of the pressure signal given
by the pressure transducer is analyzed in order
to determine whether the patient is breathing into
the mask. Reductions in therapeutic pressure
greater than 2 to 5 cm and lasting longer than
10 seconds can be documented as mask-off
events. Thus, the duration of therapeutic pressure
delivery per day (also referred to as mask time) and
number of missed days of use can be determined.
From these data, several parameters can be
calculated (percentage of days when CPAP was
used; percentage of days when CPAP was used
for >4 hours; mean daily use; mean daily use on
days CPAP was used), including mean delivery
pressure and residual apnea-hypopnea index
(AHI). This approach is usually described as
CPAP adherence tracking, although the term
Verbraecken448CPAP compliance tracking might be more appli-
cable.26 Modern CPAP devices can be interfaced
with a computer in the physician’s office or home
setting to download data. Newer modems can
interface with the CPAP unit and the integrated
chip to facilitate the reporting of remote data and
reduce the need for face-to-face visits.27 These
modems may be used as augmentation to therapy
for adherent patients or to identify and assist non-
adherent patients. In addition, smart cards can be
inserted into slots in the CPAP devices to imprint
the data. These cards are then transported to the
appropriate professional in a variety of ways,
including the use of mail carriers or other modes,
to reduce the need for direct patient travel for
routine compliance and adherence reporting.
These cards track usage hours, mask leak (liters
per second), pressure, snoring, and AHI, and
may assist sleep technicians, specialists, and
home care providers with feedback on efficacy
data to determine effective therapy and to mea-
sure outcomes. AHI measurements by some
machines have been shown to be highly correlated
with the measures recorded by PSG.28 However,
there are known problems with loss of data and
failure of recording systems (primarily smart
cards).26,29 An evolutionary development in the
collection and reporting of adherence and compli-
ance data is wireless and Internet technologies to
transmit clinical data to remote sites.27 The power-
ful ability to track daily CPAP use facilitates rapid
detection of decreased compliance, nonadher-
ence, or suboptimal apnea correction to reduce
the burden and risks and ensure cost-efficacy.
Standard follow-up
The patient should be seen by a qualified sleep
professional to assess CPAP usage (hours of use
and hours of application), to check the machine
settings, and to ensure the interface (mask,
pillows, and so forth) is in good condition. Short-
term and long-term follow-up are crucial to adher-
ence and compliance, but monitoring efficacy is
also critical to adherence, compliance, and suc-
cessful therapy. The results of the hours/usage
monitor should be discussed and the need to be
adherent to the prescribed treatment reinforced.
An annual office visit should also be scheduled
to check all the equipment and the hours/usage
and to replace masks. Changes in the patient’s
overall condition may warrant a change in CPAP
pressure (ie, weight gain may allow a higher
CPAP setting or vice versa). In one study, compli-
ance monitoring, including consistent follow-up,
troubleshooting, and feedback to both patients
and physicians, achieved good CPAP compliance
rates (4 hours per night) of greater than 80% over6 months.30 In contrast, close follow-up has not
been consistently shown to improve compliance,
but is worth doing.31 Even more effective is to
establish adherence and compliance patterns
early in treatment initiation, which can help to
resolve problems in a timely manner and is essen-
tial in the effort to establish a pattern of treatment
adherence and good compliance.21 Intervention
early in therapy may improve the patient’s early
response to CPAP therapy and increase the likeli-
hood that the patient will become a regular and
compliant user, thereby enhancing clinical
outcome.
Remote continuous positive airway pressure
monitoring and fine-tuning
Remote monitoring of health status is one of the
objectives of telemedicine.32–34 It allows clinicians
to remotely download previously recorded
data.35–39 Patients can also transmit data on a
daily basis into a database (eg, the Encore Any-
where database, Philips; ResTraxx database,
ResMed), where data extraction takes place.
Next, the data can be analyzed against a set of
preestablished criteria or filters. The data set can
be scanned for multiple criteria and compared
with thresholds for adherence and compliance,
trends, AHI, periodic breathing, occurrence of
central apneas, and mask leaks.40 Automatically
triggered clinical actions can then be scheduled.
An additional goal of such a platform is to proac-
tively identify and address issues that can nega-
tively influence CPAP adherence and
compliance. By providing patient data early in
the course of CPAP treatment, it is thought that
this technology will be extremely useful in
improving compliance and acceptance of the de-
vice in patients with sleep apnea.27,35,36,38,40–43
All that is needed is a personal computer, an
Internet connection, and the proprietary software.
Detailed reports can be generated to show usage
information and then forwarded electronically to
referral laboratories or physicians without gener-
ating additional paperwork. A modem connected
to a CPAP unit in the patient’s home automatically
dials into the server each evening. The compliance
server analyzes the data and notifies the physician
of any patients with poor CPAP usage. Patient
confidentiality is secured through a password
and login-protected system that provides protec-
tion for the patients’ information. Such systems
provide accurate, thorough, and advanced infor-
mation to clinicians and ensure that each patient
is receiving the maximum benefit from CPAP ther-
apy. Wireless applications have become available
that transmit adherence and compliance data to a
central server on a daily base, eliminating the need
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patient visits. Clinicians can check their patients at
a glance with physician summary reports. Color-
coding allows the caregiver to easily identify pa-
tients who require attention. Remote setting
changes are available to fine-tune therapy and
optimize patient management. Historical data
can be searched at any time to retrieve data that
were not transmitted via the monitoring schedule.
As a provider extender, telemedicine support for
patients initiating CPAP therapy may allow greater
practice efficiency while maintaining quality of
care. Roles, expectations, and responsibilities of
providers involved in the delivery of such services
should be defined and communicated, including
those at originating sites and distant sites.44 The
assumptions that parties may have in such en-
counters and roles should be explicitly docu-
mented. In general, the standards for supervision
should follow the same general guidelines as those
for technicians, respiratory care practitioners, and
nurses working with physicians in the live setting.
All providers involved have to review their facilities’
and institutions’ bylaws and human resource doc-
uments. Moreover, relevant regulatory documents
related to the provision of care are to be followed,
and organizations and providers are to ensure that
such care is consistent with policies regarding
scope of practice and state licensing laws of all
involved parties.44 However, it is questionable
whether service providers could be allowed to
fine-tune CPAP settings independently, because
changing treatment regimens has been the privi-
lege and responsibility of physicians for centuries.
To overcome this problem, physicians must be
available by telephone to provide assistance and
direction if needed. Telemedicine could be readily
used to augment general supervision, and asyn-
chronous methods could be used.44 However, in
some countries, CPAP fitting and troubleshooting
are not eligible for reimbursement when performed
via telemedicine by respiratory therapists and
sleep technologists.44 Nevertheless, study results
suggest that the use of telemonitored CPAP
compliance and efficacy data seems to be as
good as standard care in its effect on compliance
rates and outcomes in new CPAP users.38 Step-
nowsky and colleagues38 showed that a telemoni-
tored clinical care group had a compliance rate of
4.1 hours per night after 2 month, which repre-
sents a 46% increase in compliance compared
with the mean compliance level of the standard
clinical care group (2.8 hours per night). There
were some concerns regarding the potential loss
of data through wireless transmission. However,
the loss was negligible and, once the wireless
unit was properly connected, data from previousnights stored on the flow generator device could
be retransmitted and obtained wirelessly. Anttalai-
nen and colleagues45 compared a group of wire-
less telemonitored CPAP users with a usual-care
group, after CPAP titration. They found equal
CPAP compliance and residual AHI at 1-year
follow-up. Median nursing time was 39 minutes
in the telemonitored group and shorter than the
58 minutes per patient in the usual-care group.
Challenges for therapy monitoring
Telemedicine monitoring of sleep apnea therapy
is currently limited to CPAP and related ventilator
support devices. However, alternative treatment
modalities are becoming available. One such op-
tion is mandibular advancement devices, which
are used to optimize upper airway patency by
forcing the mandible into a forward position. It
has been shown that these devices can be objec-
tively monitored by in-built thermosensors, with
wireless transmission of adherence and compli-
ance data.46 Also, the data from CPAP devices
have to be incorporated with the data regarding
the physical status of the patients into the
e-Health sleep record. At a later stage, other as-
pects of digital technology will most likely be
incorporated. Among them, integration of relevant
health-related data collected from everyday
apparel, wearable sensors, and household appli-
ances, and increased interactivity between pa-
tients and health care providers, will improve the
anticipation and thus, it is hoped, the prevention
of the worsening of medical disease states based
on validated algorithms.PATIENT COUNSELING, THERAPY
REINFORCEMENT
The use of telemedicine, defined as the use of infor-
mation and communication technology to deliver
health care at a distance, can have a substantial
impact on health care use, strengthen the sleep
professional–patient interaction, and enhance
self-management skills.47 It has the ability to
quickly collect, transmit, and incorporate data,
making it a swift and viable means of communica-
tion between patients and their providers.48 These
features have a significant potential for the man-
agement of patients with OSA, particularly for
education andcounseling, optimizingCPAPadher-
ence and closemonitoring of effective compliance.
This type of intervention also has the added poten-
tial benefit of fostering patient empowerment.
Patients who take ownership, who are involved
in their own care, and who possess the knowledge
and skills tomanage their disease aremore likely to
comply with lifestyle modifications and treatment
Verbraecken450regimens, which in turn improves clinical
outcomes.49
Patient Counseling and Personalized Feedback
(Video and Teleconferencing)
Video and telephone contacts provide both direct
and indirect benefits to patients. Direct benefits
include decreased waiting time and increased
physician availability. Indirect benefits include
avoidance of barriers to in-person visits, such as
the cost and time associated with travel or missed
work.2 Video visits could accommodate chronic
routine follow-up appointments. Patient-specific
data, such as diaries for insomnia and CPAP
machine downloads for OSA, could be reviewed
at such visits, as could routine challenges with
equipment or medications.2 A concern could be
that the doctor might need to perform some phys-
ical examination. However, in sleep medicine it
may be that stable patients could be adequately
assessed without performing a physical examina-
tion that requires the physician to be present in the
same room. In addition, certain elements of the ex-
amination, such as weight or blood pressure mea-
surement, could be performed at home or by the
family physician. In a series of 90 patients with
OSA, 56 were seen by a physician at the sleep
center and 34 by videoconference. Satisfaction
did not differ between the groups.1
Promotion and Reinforcement of Patients’
Adherence and Compliance
Maximizing adherence and compliance is one of
the most important challenges sleep experts
face. Telemedicine has been used in various
studies to promote and reinforce CPAP treat-
ment.50–53 In most of them, a cognitive behavioral
intervention was applied by telephone,27,35,41,54,55
the Internet,35,55 and videoconference.1,36,56
Telephone
DeMolles and colleagues41 used a daily computer-
based telephone system to monitor patients’
self-reported compliance behavior and provided
automated counseling through a structured dia-
logue. The impact of the intervention was not sig-
nificant compared with standard care. However,
the findings suggest that concurrent education
and reinforcement during the initial and early treat-
ment period are effective countermeasures to
patient-reported attenuated compliance. Sparrow
and colleagues42 applied an automated telemedi-
cine intervention system, based on an algorithmic
interactive voice response system designed to
improve CPAP adherence and compliance. The
system monitors CPAP-related symptoms andpatients’ self-reported behavior and provides
feedback and counseling through a structured dia-
logue to promote CPAP usage. The monitor uses
digitized human speech to speak to the patients
and the patients communicate via the touch-tone
keypad of their telephones. Each call began with
an assessment of the self-reported duration and
frequency of CPAP usage during the past week,
followed by one of several motivational counseling
modules. If participants reported excessive side
effects or OSA symptoms, the system then recom-
mended the patients to contact their physicians to
discuss the problems. The computer system
called the patients if they did not make a call at
the expected times. Routine printed reports were
sent to the participants’ physicians biweekly dur-
ing the first month and the month thereafter. This
telemedicine approach resulted in a median
CPAP usage that was 0.9 hours per night (at
6 months) and 2.0 hours per night (at 12 months)
higher than that of an attention control group.42
Chervin and colleagues37 performed a randomized
controlled trial (RCT) among 33 patients of 2 inter-
ventions to improve compliance: one group
received weekly telephone calls to uncover any
problems and encourage use, a second group
received written information about OSA and the
importance of CPAP adherence, and a third group
served as a control group. Intervention improved
CPAP compliance and the effect was especially
strong when intervention occurred during the first
month of CPAP treatment. Isetta and colleagues57
found in a series of 50 consecutive patients with
OSA that most of them were satisfied with the tele-
consultation method, and 66% agreed that the tel-
econsultation could replace more than half of their
CPAP follow-up visits. In addition, Coma-Del-
Corral and colleagues3 found that the level of
good CPAP compliance was 85% at 6 months in
patients attending the sleep center for a face-to-
face meeting, and 75% in the teleconsultation
arm.
Sedhaoui and colleagues58 performed an RCT in
379 patients with OSA, comparing standard sup-
port completed or not within 3 months of coaching
sessions, based on telephone-based counseling
by competent staff. Sixty-five percent of the pa-
tients in the standard group showed a compliance
rate of greater than 3 hours per night, versus 75%
for the coached group. The mean CPAP usage
was 26minutes longer in the coached group versus
the standard group.
Internet
Taylor andcolleagues35 usedcomputers toprovide
daily Internet-based informational support and
feedback for problems experienced during CPAP
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sleep, and quality of sleep were sent to the partici-
pants via a computer. The patients’ responses
weremonitored by the sleepmedicine practitioner,
and the patient telephoned if deemed necessary.
There were no significant differences between the
telemedicine intervention and standard-care group
at 30 days in patient functional status and satisfac-
tion with CPAP. This intervention only provided
self-reported data to the health care provider,
whereas objective compliance and detailed physi-
ologic information may have been more useful in
effectively troubleshooting problems and may
have improved CPAP compliance.35,56,59 Further-
more, in an RCT, Fox and colleagues55 showed
improved CPAP compliance with a Web-based
telemedicine monitoring system. An autoCPAP
machine transmitted physiologic data (residual
AHI, air leak, compliance) daily to a Web site that
could be reviewed. In case problems were identi-
fied from data from the Web site, patients were
contacted by telephone as necessary. After
3 months, the mean compliance rate was signifi-
cantly greater in the telemedicine arm (191 min/d),
compared with the standard arm (105 min/d). In
contrast, 67 minutes of technician time were spent
on the patients in the telemedicine arm compared
with the standard approach. In addition, Kuna and
colleagues60 found in an RCT that providing pa-
tientswith dailyWeb-based access to their positive
airway pressure (PAP) usage improves compliance
(4.7  3.3 hours in the usual-care group,
5.9 2.5 hours and 6.3 2.5 hours in the Web ac-
cess groups with and without financial incentive,
respectively). Inclusion of a financial incentive in
the first week had no additive effect in improving
compliance. These findings are consistent with a
similar study evaluating the effect on compliance
when an interactive Web site providing PAP data
to both patients and providers is used.61
Video
Smith and colleagues36 tested a teleconferencing
approach in which a nurse visually assessed
mask fit and patients’ CPAP procedures and pro-
vided counseling and reinforcement to patients
whowere tryingCPAP again after an initial 3-month
period of poor compliance. Although the patient
education materials supplied during the initial
period did not affect adherence rates, the nurse
teleconferencing sessions during the second trial
period substantially improved the adherence of
the intervention group (9 of 10 patients vs 4 of 9 in
the placebo intervention group), suggesting that
intensity of one-on-one counseling and feedback
by a care provider is a relevant variable.36 Isetta
and colleagues57 performed an RCT in which 20patients with OSA received standard face-to-face
training, whereas another 20 received the training
via videoconference. Patients showed comparable
knowledge aboutOSAandCPAP therapy, and per-
formance of practical skills was also similar be-
tween the two groups. In another study of the
same group in 139 patients with OSA, similar levels
of CPAPcompliance, and improveddaytime sleep-
iness, quality of life, side effects, and degree of
satisfaction, were found in a telemedicine-based
CPAP follow-up strategy (televisits via video con-
ference based on Skype, e-mail, Web tool support)
compared with face-to-face management.62 Note
that the telemedicine groupmademore extra visits
than the face-to-face group, butmost of themwere
non–OSA related.Integration of Questionnaires, Rating Scales,
and Diaries
Questionnaires, rating scales, and diaries can be
useful for tracking short-term and long-term
results, provided that baseline information is
collected. Subsequent data can then be used to
monitor symptomatic improvement. Among others,
the Functional Outcomes of Sleep Questionnaire
(FOSQ) is a popular and well-validated, self-report-
ingmeasurement to assessdisease-specific health-
related quality of life, based on multiple activities of
daily living.63 The FOSQ consists of 32 questions
and is available with selected Philips (Murryville,
PA) CPAP machines. Data can be remotely down-
loaded or can be completed or uploaded on a
Web-based platform, and can be integrated in the
electronic patient record. For patients with comor-
bid insomnia, telemedicine also provides opportu-
nities to exchange and automatically process
sleep diaries and smartphone applications of
sleep-wake data, and follow online programs
related to cognitive behavior therapy (CBT).64–66 In
this way, the insomnia field can probably be transi-
tioned from evaluating more basic, noninteractive
online programs to personalized, interactive online
programs. For example, Espie and colleagues65
used a virtual therapist to help deliver a
Web-based CBT-i (CBT for insomnia) program.
Such approaches may have more important roles
in managing insomnia in the future. Apart from
insomnia, it has been shown that the CBT approach
is also effective in the context of OSA to improve
CPAP adherence.67 In cases of inadequate sleep
hygiene, platforms can be programmed with auto-
mated messages to encourage behavioral change,
without direct interaction with the sleep pro-
vider.68,69 Clinician and patient satisfaction can be
assessed using questionnaires that include visual
analog scales and open-ended questions. Patients
Verbraecken452can be asked to rate their likelihood of continuing to
use CPAP, their concern about being monitored,
and their overall satisfaction with care. The CPAP
self-efficacy scale is a 5-item self-report scale that
was developed by Stepnowsky and colleagues.70
The list of opportunities is almost unlimited. Online
platforms will facilitate the movement from
disease-based care into patient-based medicine.
Such asynchronous tools may provide important
diagnostic and therapeutic information. The infor-
mation from these tools should be easily accessible
to sleep providers.44
BARRIERS IN THE IMPLEMENTATION OF
TELEMEDICINE
Telemedicine aligns with the shift in national focus
from technology being used in isolation to technol-
ogy being the means to both expand the reach of
health care and to integrate health care services
across patients and organizations. Its adoption
has been hampered by a multitude of barriers.
Receptiveness and Willingness of Health Care
Providers and Patients
At present, expansion of telemedicine into all
aspects of sleep disorder management is limited
by the willingness of physicians, patients, and
health care organizations to accept telemedicine
as an alternative to in-office care.44 The settings
from which patients and physicians originate may
influence the perception or acceptance of tele-
medicine.1 Croteau and colleagues71 showed
that physicians in urban areas tend to be unwilling
to dedicate time to learning how to use new tele-
medicine equipment. However, if the technology
is easy to use, the correlation between ease and
implementation is positive. In a study of rural com-
munities, Campbell and colleagues72 found that
physicians are more likely to adopt telemedicine
technology if they perceive an increased capability
of telemedicine to accommodate the constant
advance of technology. In both rural and urban
areas, perceived usefulness had the most signifi-
cant impact on the decision by health care pro-
viders to adopt telemedicine. As long as
telemedicine can be proved to be a useful tool
for health care, the willingness of physicians to
use telemedicine technology remains positive.
Nevertheless, clinicians’ feedback should be
further assessed and their involvement promoted
as main factor in guaranteeing a successful
telemedicine implementation.73,74 In general,
research indicates that telemedicine has been
well received by patients with OSA,1,36 as well as
by patients with other medical conditions.75,76
The greatest advantages of telemedicine thathave been identified are more convenience and
decreased travel burden.Privacy Concerns and Confidentiality
Systems need to be developed to protect patient
privacy when CPAP adherence and compliance
data reports are reviewed and maintained on
servers. A significant current problem in the moni-
toring of CPAP performance is the ability to track
patients with the location data that are trans-
mitted. This ability would violate the right for
privacy for the patients being treated. Also, a ser-
vice provider whomonitors not only the usage time
but also the flow pattern can provide a diagnosis of
the reoccurring sleep apnea as well; for example, it
may be caused by a worsening of the disease over
time. The patient could be alerted to contact the
sleep center, or the applied CPAP pressure could
be adjusted remotely. Legal issues may arise,
because this is comparable with a medical inter-
vention, such as changing a medication dosage,
and such an approach is not allowed in all health
care systems.44 Also, integration of the telemoni-
tored data in the patient sleep record by the
home care provider is limited by privacy issues.
In France, all these privacy concerns have now
led the courts to conclude that there are no legal
grounds to allow telemonitoring. Therefore, a
robust level of information security for transmis-
sion, storage, and access of the data and at the
platform in which the data reside is mandatory to
implement telemedicine acceptably. This security
encompasses strong authentication, data encryp-
tion (for both live and stored information), nonrep-
udiation services, audit logs, a common security
policy, and controlled contracts between partners.
The American Academy of Sleep Medicine
(AASM) also explicitly describes the following
requirements: muting availability; passphrase
requirement to access device on which patient
data are stored; inactivity timeout function
requiring reauthentication with timeout not
exceeding 15 minutes; protected health informa-
tion and confidential data only stored on secure
data storage locations; provider knowledge on
how patient data are stored and ability to answer
patient questions regarding storage of protected
health information; access granted only to autho-
rized users; data streamed directly to storage to
avoid accidental or unauthorized file sharing.44 All
these requirements are based on American Tele-
medicine Association guidelines.77 To encounter
security requirements, different data (interchange)
standards have been developed.78 These stan-
dards include the primary clinical messaging
format standards (eg, the Health Level Seven
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ical images; National Council for Prescription Drug
Programs script for retail pharmacy messaging;
Institute of Electrical and Electronics Engineers
(IEEE) standards for medical devices; and Logical
Observation Identifiers, Names, and Codes for
reporting of laboratory results.78 Encryption algo-
rithms have been developed for the encryption of
electronic data, like the Data Encryption Standard
(DES), but the DES was shown to be insecure,
because the algorithm was broken in 1993.79 In
addition, the Needham-Schroeder protocol was
proved to be insecure more than a decade after
its publication.80,81 More up-to-date encryption
standards are the Advanced Encryption Standard
(AES), DES-X, GDES, and Triple DES standards,
which have been shown to be secure.82 Alterna-
tives for the DES standard are several replacement
algorithms (RC5, Blowfish, IDEA, NewDES,
SAFER, CAST5, FEAL, GOST 28147–89, RC6,
Serpent, MARS, and Twofish, amongmany others)
with higher security and faster operation.82,83
For image transfer, specific algorithms have
been developed, like the Joint Watermarking-
Encryption, which offers confidentiality, integrity,
authenticity, and traceability functionalities,84 and
newer algorithms that combine traditional image
encryption and image hiding with chaos theory,
with improved processing.85 Nonrepudiation im-
plies that a person cannot deny responsibility for
a certain transaction. This principle is important to
maintain in audits because a person implicated by
an audit should not be able to repudiate responsi-
bility.79,86,87 Data-access standards for electronic
health records (EHRs) are also increasingly being
implemented, such as the Fast Health Interopera-
bility Resources, and theSubstitutableMedical Ap-
plications Reusable Technologies (SMART) Health
IT apps interface.88 From the patient perspective,
patient-powered networks are asking for easy
download and exchange of their EHR data. Some
(unsuccessful) technologies for this purpose were
the Consolidated Clinical Document Architecture
and theBlueButton.89 The requirement for certified
EHR technologies to provide an application pro-
gramming interface will enable patients to get ac-
cess to their EHR data in a timely fashion.88 Legal
liability can be avoided by providing policies and
standards for health care providers to observe,
like the Health Insurance Portability and Account-
ability Act (HIPAA) andHL7, which are the standard
for encrypting communications and storing medi-
cal data in the United States and the United
Kingdom.90–92 Nonrepudiation is necessary to
comply with HIPAA, and thus needs to be
addressed by all telemedicine systems targetedtoward theUnitedStates.87 Also, clear contingency
plans are required in the event of loss of communi-
cations.90,91 In addition, controlled contracts be-
tween partners are recommended. Such
measures are feasible between hospital organiza-
tions, and hence for physician-physician contacts,
but raise concerns over the ability to develop
secure patient-to-physician (or vice versa) data
transfer. By only transmitting data relevant to the
problem in question, using storing and transmis-
sion methods where confidentiality and security
are guaranteed, and obtaining informed consent
from the patient are ways in which these concerns
can be minimized.Financial Barriers
Although telematic transmission of CPAP adher-
ence and compliance data is the future, a major
problem with wireless systems is having the addi-
tional resources to retrieve the data,44 and to cover
the costs for providers’ services, transmission
modules, home installation, licensing fees, tele-
phone charges, security, and additional work by
the sleep professionals.93 These costs should be
anticipated by the health care authorities before
introducing these technologies. Moreover, despite
the evident potential of telemedicine-based inter-
ventions, the precise benefits, risks, and costs of
this method to deliver health care remain
unclear.94 In a systematic review, telemedicine
and telecare services were found to be no more
cost-effective than standard health care strate-
gies.95 In one sleep medicine study, the cost of
the interventions, including material costs, was
lower than the same number of face-to-face
visits,36 whereas another study reported lower to-
tal costs because of savings on transport and less
lost productivity (indirect costs).62 Therefore, a
telemedicine-based approach could be especially
advantageous if applied to the working population
and to residents in medically underserved areas.
However, it is important to target and customize
these interventions to patients who are most likely
to benefit from them. Ultimately, clinicians should
also carefully select the appropriate outcomes
that telemedicine strategies seek to effect.96 For
example, telemedicine encompasses expanded
patient access to quality sleep health care.97–99
Moreover, protocols need to be developed that
describe the roles, expectations, and responsibil-
ities of health care providers, hospitals, physi-
cians, and patients involved in the delivery of
sleep telemedicine, because it is not clear when,
how, and who should monitor the wireless trans-
missions. In addition, long-term studies with
cost-effectiveness analyses are needed.
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There are other barriers to incorporating wireless
transmission systems routinely in clinical practice.
If hospitals make use of different CPAP brands,
they will be urged to switch to a single brand in or-
der to control the telemedicine costs. The lack of
standardization also precludes interoperability
with existing electronic patient records, and data
profiles are not standardized between the different
providers. Moreover, current electronic patient
records are not configured for this type of data
management. In addition, there is also the poten-
tial for network complications when using a tele-
communications network, latency, as well as
disconnection. This concern is legitimate, because
the potential for complications is a reality.100 A
general concern for telemedicine application in-
cludes the lack of reliable Internet access outside
of large cities and inadequate bandwidth for
high-resolution images or videoconferencing.101
Future Platforms
In the older platforms, the organization and man-
agement of datawere based on a centralized server
operating throughacall center,with several inherent
financial and legal aspects between hospitals and
providers.51 With low-cost miniature integrated
circuits now available, new devices have been
developed that enable a decentralized communica-
tions architecture, whereas the patient’s home no
longer has tobe equippedwith any telecommunica-
tions infrastructure. Also, smartphone applications
are now checked for their diagnostic value, in addi-
tion to just monitoring sleep behavior. These devel-
opments are rarely validated against medical
standards and the diagnostic value is unknown.
However, because they allow the transmission of
data to the cloud, or even a personal Web page,
this is another area in sleep telemedicine that is be-
ing realized.102 However, tracking of patients may
alsobean issuewhenusingSIM (Subscriber Identity
Module) cards, which allow tracking through the
wireless transmission cell structure. When the user
changes locations, it stores the Location Area Iden-
tity number to theSIMand sends it back to the oper-
ator network with its new location.103 Security here
is also an issue, particularly when SIM cards use
the DES, which is, despite its age, still used by
some operators. Cards using the more recent AES
or Triple DES standards are secure.104 Neverthe-
less, at themoment, these smartphone applications
are gadgets in the framework of quantifying an indi-
vidual, but are not medical supportive tools.105 It is
expected that a full combination of biomedical sen-
sors andmobile phoneswill also help to incorporate
telemedicine into routine practice. However, in agroup of 107 high-cardiovascular-risk patients
with OSA, telemonitoring of self-measured home
bloodpressure, physical activity, andCPAPcompli-
ance based on smartphone intervention failed to
improve adherence or blood pressure. The investi-
gators speculated that it is possible that telemedi-
cine could be perceived as an additional burden
associated with the self-management of blood
pressure and CPAP.106
Quality Concerns
As recommended by the AASM, clinical standards
for telemedicine services should mirror those of
live office visits, including all aspects of diagnosis
and treatment decisions as would be reasonably
expected in office-based encounters.44 Inherently,
physical examination is not possible as it is per-
formed in a face-to-face visit, but is not critical in
a sleep medicine setting. Therefore, clinical judg-
ment is mainly based on anamnesis and detailed
metrics and analytics. Resources should be
made available to reimburse these facilities in a
manner competitive or comparable with traditional
in-person visits and this will make it feasible to pro-
mote a care model in which the different parties
involved collaborate and interact, resulting in a
better value of health care delivery in a coordi-
nated fashion. Consecutively, this also means
that appropriate technical standards have to be
upheld through the complete telemedicine care
delivery process. Therefore, quality assurance
processes have to be introduced as well, to ensure
the optimal level of patient outcomes, process
measures, and user experience. Quality improve-
ment based on data management and quality pro-
cessing should also be recognized and financially
appreciated. Such programs should encompass
process measures, patient-centered outcomes,
overall provider experience and satisfaction, tech-
nical ease, and encryption of communications and
storage. Strict application of the highest profes-
sional and ethical standards is required, with the
aim of improving overall patient access, quality,
and value of care. Such an approach benefits
from financial transparency throughout the
process.44
Legal Concerns
Apart from patient privacy, confidentiality, and se-
curity concerns, other legal obstacles could arise
that focus on the licensure of physicians. It is a uni-
versal requirement that physicians practicing
within a country must be licensed in that country,
whereas in telemedicine, physicians deliver medi-
cal treatment across state lines and, possibly, in-
ternational borders.
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medical services can sometimes be inconsistent
and vague, and can increase liability concerns.
Some countries do not allow controlled sub-
stances (eg, sedative hypnotics) to be prescribed
to patients whom the provider has not seen in a
face-to-face encounter. Also, as discussed earlier,
data protection and data security are the number
1 issue in any telemedicine application. The EU
Directives on the Processing of Personal Data
and the Protection of Privacy in the Electronic
Communication Sector describe several specific
requirements relating to confidentiality and secu-
rity that telemedicine services have to meet in or-
der to safeguard individuals’ rights.107–109
If such security can be guaranteed, telemedicine
can easily be performed, because any form of
communication that does not relate to an identified
or identifiable natural person is not subject to the
multitude of data protection laws.107,109 Other Eu-
ropean legal achievements related to e-Health are
the E-Commerce Directive, the Medical Device
Directive, and the Directive on Distance Contract-
ing. These directives are not adopted especially
for e-Health applications, but are indirectly impor-
tant. For store-and-forward encounters that may
use digital images of patients for the purpose of
rendering a diagnosis or medical opinion, without
the presence of the patient, this has been proved
feasible for some specialties, like radiology
(teleradiology), pathology (telepathology), and
dermatology (teledermatology).110,111 Sleep elec-
troencephalography and polysomnography can
also have the interpretation performed remotely.44
However, in telemedicine with more complex pa-
tient/physician encounters using electronic
communication and electronic patient records
with personally identifiable data, this will be a less
achievable goal. Nevertheless, the confidentiality
of telemedicine is affected by the inherent risk of
third parties intercepting the communication. For
example, if a confidential communication is dis-
closed to a third party, it is not deemed to be confi-
dential, and therefore the physician-patient
privilege does not apply.100 In France, the concept
of telemedicine was formalized in the 2009 Hospi-
tal, Patients, Health Territories national law and the
2010 decree through which it was applied.112 Since
then, doubts have remained, and, less than 5 years
later, sleep telemedicine and remote CPAP compli-
ance monitoring were put on hold, because of
privacy concerns. Cloud applications are now
being used in some ambitious health care applica-
tions, drawing together huge amounts of data
from disparately located computers, which implies
data sharing across jurisdictions and the sharing
of responsibilities by a range of different datacontrollers.113 This process could be said to be
opening Pandora’s Box.SUMMARY
Various methods are available to assess adher-
ence and compliance with nasal CPAP at home.
Objective data can be obtained by either down-
loads from the memory card of the CPAP device
or by direct interrogation of CPAP devices that
do not have memory cards. Telemedicine applica-
tions can be useful to monitor and motivate pa-
tients on a large scale. There are emerging
mechanisms for supporting virtual visits and
remote monitoring if they can be shown to be
financially competitive. Inclusion of sham telemed-
icine control arms might determine whether
increased adherence might have been caused by
the perception of monitoring by the patients, or
by the more prompt institution of clinical interven-
tions. As this new frontier is explored, it is of para-
mount importance to be aware of how to use this
technology safely, and within the health care sys-
tem’s current legal confines. In addition, careful
telemedicine management will provide a more
seamless communication flow, to the benefit of
medical providers, the global health care system,
and ultimately for patients.REFERENCES
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